Your browser doesn't support javascript.
loading
Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis.
López-Rodríguez, Rosario; Ferreiro-Iglesias, Aida; Lima, Aurea; Bernardes, Miguel; Pawlik, Andrzej; Paradowska-Gorycka, Agnieszka; Swierkot, Jerzy; Slezak, Ryszard; Gonzalez-Alvaro, Isidoro; Narvaez, Javier; Pérez-Pampín, Eva; Mera-Varela, Antonio; Vidal-Bralo, Laura; Acuña-Ochoa, José Gorgonio; Conde, Carmen; Gonzalez, Antonio.
Afiliação
  • López-Rodríguez R; Experimental and Observational Rheumatology and Rheumatology Unit. Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Ferreiro-Iglesias A; Experimental and Observational Rheumatology and Rheumatology Unit. Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Lima A; CESPU, Institute of Research & Advanced Training in Health Sciences & Technologies, Drug Discovery, Delivery & Toxicology Group, Gandra PRD, Portugal.
  • Bernardes M; Molecular Oncology & Viral Pathology Group - Research Center, Portuguese Institute of Oncology of Porto, Porto, Portugal.
  • Pawlik A; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Paradowska-Gorycka A; Rheumatology Department, São João Hospital Center, Porto, Portugal.
  • Swierkot J; Department of Physiology, Pomeranian Medical University Szczecin, Szczecin, Poland.
  • Slezak R; Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
  • Gonzalez-Alvaro I; Department of Rheumatology, Wroclaw Medical University, Wroclaw, Poland.
  • Narvaez J; Department of Genetics, Medical University of Wroclaw, Wroclaw, Poland.
  • Pérez-Pampín E; Rheumatology Department, Instituto de Investigacion del Hospital de La Princesa (IIS-IP), Madrid, Spain.
  • Mera-Varela A; Department of Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain.
  • Vidal-Bralo L; Experimental and Observational Rheumatology and Rheumatology Unit. Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Acuña-Ochoa JG; Experimental and Observational Rheumatology and Rheumatology Unit. Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Conde C; Experimental and Observational Rheumatology and Rheumatology Unit. Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Gonzalez A; Experimental and Observational Rheumatology and Rheumatology Unit. Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Pharmacogenomics J ; 18(4): 539-545, 2018 07.
Article em En | MEDLINE | ID: mdl-29520081
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Artrite Reumatoide / Metotrexato / Análise Custo-Benefício Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Artrite Reumatoide / Metotrexato / Análise Custo-Benefício Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha